Metabolomics reveals metabolite changes in acute pulmonary embolism

Journal of Proteome Research

Volumn 13, Issue 2, 2014, Pages 805-816

  Bujak, Renata ^a,b   García Álvarez, Ana ^c,d   Rupérez, Francisco J ^a   Nuño Ayala, Mario ^c   García, Antonia ^a   Ruiz Cabello, Jesus ^c,e   Fuster, Valentín ^c   Ibáñez, Borja ^c,f   Barbas, Coral ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

metabolic fingerprinting; metabolomics; pig; pulmonary embolism; pulmonary hypertension

Indexed keywords

ACUTE DISEASE; ANIMALS; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, LIQUID; HUMANS; MALE; MASS SPECTROMETRY; METABOLOMICS; PULMONARY EMBOLISM; SWINE;

EID: 84893866868     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400872j     Document Type: Article

References (51)

1. Torbicki, A.; Perrier, A.; Konstantinides, S.; Agnelli, G.; Galie, N.; Pruszczyk, P.; Bengel, F.; Brady, A. J. B.; Ferreira, D.; Janssens, U.; Klepetko, W.; Mayer, E.; Remy-Jardin, M.; Bassand, J. P. Guidelines on the diagnosis and management of acute pulmonary embolism Eur. Heart J. 2008, 29 (18) 2276-315
2. Tapson, V. F. Acute pulmonary embolism N. Engl. J. Med. 2008, 358 (10) 1037-52
3. Montagnana, M.; Cervellin, G.; Franchini, M.; Lippi, G. Pathophysiology, clinics and diagnostics of non-thrombotic pulmonary embolism J. Thromb. Thrombolysis 2011, 31 (4) 436-44
4. Kostadima, E.; Zakynthinos, E. Pulmonary Embolism: Pathophysiology, Diagnosis, Treatment Hell. J. Cardiol. 2007, 48 (2) 94-107
5. Kearon, C. Diagnosis of pulmonary embolism Can. Med. Assoc. J. 2003, 168 (2) 183-94
6. Di Nisio, M.; Squizzato, A.; Rutjes, A. W. S.; Buller, H. R.; Zwinderman, A. H.; Bossuyt, P. M. M. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review J. Thromb. Haemostasis 2007, 5 (2) 296-304
7. Huisman, M. V.; Klok, F. A. Diagnostic management of clinically suspected acute pulmonary embolism J. Thromb. Haemostasis 2009, 7 (Suppl. 1) 312-17
8. Reinartz, P.; Wildberger, J. E.; Schaefer, W.; Nowak, B.; Mahnken, A. H.; Buell, U. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT J. Nucl. Med. 2004, 45 (9) 1501-8
9. Pengo, V.; Anthonie, V.; Lensing, W. A.; Prins, M. H.; Marchiori, A.; Davidson, B. L.; Tiozzo, F.; Albanese, P.; Biasiolo, A.; Pegoraro, C.; Iliceto, S.; Prandoni, P. Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism N. Engl. J. Med. 2004, 350 (22) 2257-64
10. Barbash, I. M.; Schenke, W. H.; Halabi, M.; Ratnayaka, K.; Faranesh, A. Z.; Kocaturk, O.; Lederman, R. J. Experimental model of large pulmonary embolism employing controlled release of subacute caval thrombus in swine J. Vasc. Interventional Radiol. 2011, 22 (10) 1471-7
11. Böttiger, B. W.; Motsch, J.; Dörsam, J.; Mieck, U.; Gries, A.; Weimann, J.; Martin, E. Inhaled nitric oxide selectively decreases pulmonary artery pressure and pulmonary vascular resistance following acute massive pulmonary microembolism in piglets Chest 1996, 110 (4) 1041-7
12. Fiehn, O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks Comp. Funct. Genomics 2011, 2 (3) 155-68
13. Shulaev, V. Metabolomics technology and bioinformatics Briefings Bioinf. 2006, 7 (2) 128-39
14. Lenz, E. M.; Wilson, I. D. Analytical strategies in metabonomics J. Proteome Res. 2007, 6 (2) 443-58
15. Ciborowski, M.; Teul, J.; Martin-Ventura, J. L.; Egido, J.; Barbas, C. Metabolomics with LC-QTOF-MS Permits the Prediction of Disease Stage in Aortic Abdominal Aneurysm Based on Plasma Metabolic Fingerprint PLoS One 2012, 7 (2) e31982
16. Whiley, L.; Godzien, J.; Ruperez, F. J.; Legido-Quigley, C.; Barbas, C. In-vial dual extraction for direct LC-MS analysis of plasma for comprehensive and highly reproducible metabolic fingerprinting Anal. Chem. 2012, 84 (14) 5992-9
17. Ciborowski, M.; Lipska, A.; Godzien, J.; Ferrarini, A.; Korsak, J.; Radziwon, P.; Tomasiak, M.; Barbas, C. Combination of LC-MS- and GC-MS-based Metabolomics to Study the Effect of Ozonated Autohemotherapy on Human Blood J. Proteome Res. 2012, 11 (12) 6231-41
18. Garcia, A.; Barbas, C. Gas Chromatography-Mass Spectrometry (GC-MS)-Based Metabolomics. In Metabolic Profiling, Methods in Molecular Biology; Metz, T. O., Ed.; Springer: New York, NY, 2011; Vol. 708, pp 191-204.
19. Gika, H.; Macpherson, E.; Theodoridis, G.; Wilson, I. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2008, 871 (2) 299-305
20. Solaini, G.; Baracca, A.; Lenaz, G.; Sgarbi, G. Hypoxia and mitochondrial oxidative metabolism Biochim. Biophys. Acta 2010, 1797 (6) 1171-7
21. Archer, S. L.; Fang, Y.-H.; Ryan, J. J.; Piao, L. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension Pulm. Circ. 2013, 3 (1) 144-52
22. LaManna, J. C.; Salem, N.; Puchowicz, M.; Erokwu, B.; Koppaka, S.; Flask, C.; Lee, Z. Ketones suppress brain glucose consumption Adv. Exp. Med. Biol. 2009, 645, 301-6
23. Sylvester, J. T.; Shimoda, L. A.; Aaronson, P. I.; Ward, J. P. T. Hypoxic pulmonary vasoconstriction Physiol. Rev. 2012, 92, 367-520
24. Leach, R. M.; Hill, H. M.; Snetkov, V. A.; Robertson, T. P.; Ward, J. P. Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat: identity of the hypoxic sensor J Physiol. 2011, 536 (1) 211-24
25. Rubin, M.; Tuder, L.; Davis, A.; Graham, B. B. Targeting Energetic Metabolism. A New Frontier in the Pathogenesis and Treatment of Pulmonary Hypertension Am. J. Respir. Crit. Care Med. 2012, 185 (3) 260-6
26. Piao, L.; Fang, Y.-H.; Cadete, V. J. J.; Wietholt, C.; Urboniene, D.; Toth, P. T.; Marsboom, G.; Zhang, H. J.; Haber, I.; Rehman, J.; Lopaschuk, G. D.; Archer, S. L. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle J. Mol. Med. 2010, 88, 47-60
27. Rehman, J.; Archer, S. L. A Proposed Mitochondrial-Metabolic Mechanism for Initiation and Maintenance of Pulmonary Arterial Hypertension in Fawn-Hooded Rats: The Warburg Model of Pulmonary Arterial Hypertension. In Membrane Receptors, Channels and Transporters in Pulmonary Circulation, Advances in Experimental Medicine and Biology; Yuan, J. X.-J.; Ward, J. P. T., Eds.; Springer: New York, NY, 2010; Vol. 661, pp 171-185.
28. Lord, R. S.; Bralley, J. A. Clinical applications of urinary organic acids. Part I: Detoxification markers Altern. Med. Rev. 2008, 13 (3) 205-15
29. Frezza, C.; Zheng, L.; Tennant, D. A.; Papovsky, D. B.; Hedley, B. A.; Kalna, G.; Watson, D. G.; Gottlieb, E. Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival PLoS One 2011, 6 (9) e24411
30. Yin, J.; Gao, Z.; He, Q.; Ye, J. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue Am. J. Physiol.: Endocrinol. Metab. 2009, 296 (2) 333-42
31. Lambert, I. H.; Pedersen, S. F.; Poulsen, K. A. Activation of PLA2 isoforms by cell swelling and ischaemia/hypoxia Acta Physiol. (Oxford) 2006, 187 (1-2) 75-85
32. Funk, C. D. Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology Science 2001, 294 (5548) 1871-75
33. Raj, J. U.; Chen, P. Role of eicosanoids in hypoxic vasoconstriction in isolated lamb lungs Am. J. Physiol.: Heart Circ. Physiol. 1987, 253 (3 Pt 2) 626-33
34. Jones, J. E.; Walker, J. L.; Song, Y.; Weiss, N.; Cardoso, W. V.; Tuder, R. M.; Loscalzo, J.; Zhang, Y. Y. Effect of 5-lipoxygenase on the development of pulmonary hypertension in rats Am. J. Physiol.: Heart Circ. Physiol. 2004, 286 (5) 1775-84
35. Weissmann, N.; Sommer, N.; Schermuly, R. T.; Ghofrani, H. A.; Seeger, W.; Grimminger, F. Oxygen sensors in hypoxic pulmonary vasoconstriction Cardiovasc. Res. 2006, 71 (4) 620-9
36. Bartke, N.; Hannun, Y. A. Bioactive sphingolipids: metabolism and function J. Lipid Res. 2009, 50 (Suppl.) 91-6
37. Cogolludo, A.; Moreno, L.; Frazziano, G.; Moral-Sanz, J.; Menendez, C.; Castañeda, J.; González, C.; Villamor, E.; Perez-Vizcaino, F. Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction Cardiovasc. Res. 2009, 82 (2) 296-302
38. Geoffroy, K.; Wiernsperger, N.; Lagarde, M.; El Bawab, S. Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids J. Biol. Chem. 2004, 279 (33) 34343-52
39. Ma, S.; Turino, G. M.; Lin, Y. Y. Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2011, 879 (21) 1893-8
40. Huang, J. T. H.; Chaudhuri, R.; Albarbarawi, O.; Barton, A.; Grierson, C.; Rauchhaus, P.; Weir, C. J.; Messow, M.; Stevens, N.; McSharry, C.; Feuerstein, G.; Mukhopadhyay, S.; Brady, J.; Palmer, C. N. A.; Miller, D.; Thomson, N. C. Clinical Validity of Plasma and Urinary Desmosine as Biomarkers for Chronic Obstructive Pulmonary Disease Thorax 2012, 67 (6) 502-8
41. Schermuly, R. T.; Ghofrani, H. A.; Wilkins, M. R.; Grimminger, F. Mechanisms of disease: pulmonary arterial hypertension Nat. Rev. Cardiol. 2011, 8 (8) 443-55
42. Cottrill, K. A.; Chan, S. Y. Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect Eur. J. Clin. Invest. 2013, 10.1111/eci.12104
43. Agrawal, A.; Guttapalli, A.; Narayan, S.; Albert, T. J.; Shapiro, I. M.; Risbud, M. V. Normoxic stabilization of HIF-1 drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk Am. J. Physiol.: Cell Physiol. 2007, 293 (2) 621-31
44. 18F-Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Pulmonary Arterial Hypertension Am. J. Respir. Crit. Care Med. 2012, 185 (6) 670-9
45. Lopez-Barneo, J.; Pardal, R.; Ortega-Sáenz, P. Cellular mechanism of oxygen sensing Annu. Rev. Physiol. 2001, 63, 259-87
46. Rabinovitch, M. Molecular pathogenesis of pulmonary arterial hypertension J. Clin. Invest. 2012, 122 (12) 4306-13
47. Land, S. C.; Tee, A. R. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif J. Biol. Chem. 2007, 282 (28) 20534-43
48. Laplante, M.; Sabatini, D. M. An emerging role of mTOR in lipid biosynthesis Curr. Biol. 2009, 19 (22) 1046-52
49. Wymann, M. P.; Schneiter, R. Lipid signalling in disease Nat. Rev. Mol. Cell Biol. 2008, 9 (2) 162-76
50. Gurbanov, E.; Shiliang, X. The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension Eur. J. Cardiothorac. Surg. 2006, 30 (3) 499-507
51. Goncharova, E. A. mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects FASEB J. 2013, 27 (5) 1796-807